Lasting scars: The impact of depression in early adulthood on subsequent labor market outcomes Buyi Wang, Richard G. Frank, and Sherry Glied Tuesday, December 20, 2022
Making progress on integration of behavioral health care and other medical care Richard G. Frank and Vikki Wachino Monday, December 12, 2022
Meeting the moment on children’s mental health: Recommendations for federal policy Richard G. Frank, Vikki Wachino, and Karina Aguilar Monday, December 12, 2022
Some drugs that improve price competition fall through the cracks of FDA user fees Marta E. Wosińska and Richard G. Frank Monday, December 12, 2022
People are underestimating the significance of drug pricing provisions in Inflation Reduction Act Rena M. Conti, Leslie Dach, and Richard G. Frank Thursday, October 13, 2022
Comments on the Request for Information on Medicare Loren Adler, Matthew Fiedler, Richard G. Frank, and Marta E. Wosińska Wednesday, September 7, 2022
Auditing the prescription drug Consumer Price Index Richard G. Frank, Ernst R. Berndt, and Andrew L. Hicks Friday, August 26, 2022
Accelerated approval of cancer drugs: No economic reward for drug makers that conduct confirmatory trials Richard G. Frank, Ezekiel Emanuel, and Mahnum Shahzad Thursday, August 18, 2022
Familiar complaints and distortions with little merit from the pharmaceutical industry Richard G. Frank Thursday, August 11, 2022
International reference pricing in the context of U.S. drug policy Richard G. Frank, Rena M. Conti, and Jonathan Gruber Tuesday, July 26, 2022
